Title: Stopping Overdoses of Fentanyl Analogues Act
Policy area: Crime and Law Enforcement

Summary:
Stopping Overdoses of Fentanyl Analogues Act
This bill amends the Controlled Substances Act to add certain fentanyl analogues to schedule I. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 1553 Introduced in Senate (IS)]

<DOC>






115th CONGRESS
  1st Session
                                S. 1553

 To amend the Controlled Substances Act to list fentanyl analogues as 
                   schedule I controlled substances.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             July 13, 2017

  Mr. Johnson introduced the following bill; which was read twice and 
               referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL


 
 To amend the Controlled Substances Act to list fentanyl analogues as 
                   schedule I controlled substances.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stopping Overdoses of Fentanyl 
Analogues Act''.

SEC. 2. FENTANYL ANALOGUES.

    Section 202(c) of the Controlled Substances Act (21 U.S.C. 812) is 
amended--
     (a) by adding at the end of subsection (b) of Schedule I the 
following:
            ``(23) Acetyl fentanyl 4-methylphenethyl.
            ``(24) Acrylfentanyl.
            ``(25) 4-fluorobutyrylfentanyl.
            ``(26) 4-fluoroisobutyryl fentanyl.
            ``(27) 3-furanyl fentanyl.
            ``(28) Isobutyryl fentanyl.
            ``(29) Meta-fluorofentanyl.
            ``(30) Methoxyacetyl fentanyl.
            ``(31) 4-methoxybutyrfentanyl.
            ``(32) Ocfentanil.
            ``(33) Ortho-fluorofentanyl.
            ``(34) Tetrahydrofuranyl fentanyl.
            ``(35) Valeryl fentanyl.''; and
    (b) by adding at the end of Schedule I the following:
    ``(e)(1) Unless specifically exempted or unless listed in another 
schedule, any material, compound, mixture, or preparation which 
contains any quantity of fentanyl analogues, or which contains their 
salts, isomers, and salts of isomers whenever the existence of such 
salts, isomers, and salts of isomers is possible within the specific 
chemical designation.
    ``(2) In paragraph (1), the term `fentanyl analogues' includes any 
compound structurally derived from fentanyl--
            ``(A) by replacement of the phenyl portion of the phenethyl 
        group by any monocycle, whether or not further substituted in 
        or on the monocycle;
            ``(B) by substitution in or on the phenethyl group with 
        alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or 
        nitro groups;
            ``(C) by substitution in or on the piperidine ring with 
        alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl, 
        amino or nitro groups;
            ``(D) by replacement of the aniline ring with any aromatic 
        monocycle whether or not further substituted in or on the 
        aromatic monocycle; or
            ``(E) by replacement of the N-propionyl group by another 
        acyl group.''.
                                 <all>